Not investment advice.Read full disclaimer
Continue with finqOS
Side-by-side valuation, growth, and profitability metrics against the closest competitors.
14-day free trial · No credit card required
52W Range
Volume
Mkt Cap
P/E
Div Yield
Publicly traded Narayana Hrudayalaya Limited (NH.NS) competitors and peer companies. Compare valuation, revenue growth, margins, and profitability against Ipca Laboratories Limited, Ipca Laboratories Limited, Gland Pharma Limited, Gland Pharma Limited, Aster DM Healthcare Limited, and more.
| Ticker | Company | Market Cap |
|---|---|---|
| IPCALAB.BO | Ipca Laboratories Limited | $424.6B |
| IPCALAB.NS | Ipca Laboratories Limited | $421.9B |
| GLAND.BO | Gland Pharma Limited | $408.4B |
| GLAND.NS | Gland Pharma Limited | $408.2B |
| ASTERDM.NS | Aster DM Healthcare Limited | $402.8B |
| ASTERDM.BO | Aster DM Healthcare Limited | $402.3B |
| MEDANTA.BO | Global Health Limited | $356.0B |
| MEDANTA.NS | Global Health Limited | $353.2B |
| KIMS.BO | Krishna Institute of Medical Sciences Limited | $331.3B |
| KIMS.NS | Krishna Institute of Medical Sciences Limited | $331.1B |